Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial ; volume:14 ; number:1 ; day:15 ; month:9 ; year:2014 ; pages:1-6 ; date:12.2014
BMC cancer ; 14, Heft 1 (15.9.2014), 1-6, 12.2014
- Urheber
-
Decaestecker, Karel
- Beteiligte Personen und Organisationen
-
De Meerleer, Gert
Ameye, Filip
Fonteyne, Valerie
Lambert, Bieke
Joniau, Steven
Delrue, Louke
Billiet, Ignace
Duthoy, Wim
Junius, Sarah
Huysse, Wouter
Lumen, Nicolaas
Ost, Piet
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-671
- URN
-
urn:nbn:de:1111-2016030416181
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Decaestecker, Karel
- De Meerleer, Gert
- Ameye, Filip
- Fonteyne, Valerie
- Lambert, Bieke
- Joniau, Steven
- Delrue, Louke
- Billiet, Ignace
- Duthoy, Wim
- Junius, Sarah
- Huysse, Wouter
- Lumen, Nicolaas
- Ost, Piet
- SpringerLink (Online service)
Ähnliche Objekte (12)
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?